Effects of endogenous insulin-like growth factor binding protein-3 on cell cycle regulation in breast cancer cells

Growth Factors

Volumn 27, Issue 6, 2009, Pages 394-408

  O'Han, Michelle K ^a   Baxter, Robert C ^a   Schedlich, Lynette J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Breast cancer cells; Cell cycle regulation; IGFBP 3; Migration; RNA interference

Indexed keywords

CYCLIN A; CYCLIN D1; DNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P27; SMALL INTERFERING RNA; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL COUNT; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; MONOLAYER CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RETINOBLASTOMA; TREATMENT FAILURE; WOUND HEALING;

BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; RNA INTERFERENCE;

EID: 70450207978     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977190903185032     Document Type: Article

References (62)

1. Baxter RC, Martin JL. 1986. Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma. J Clin Invest 78:1504-1512.
2. Benini S, Zuntini M, Manara MC, Cohen P, Nicoletti G, Nanni P, Oh Y, Picci P, Scotlandi K. 2006. Insulin-like growth factor binding protein 3 as an anticancer molecule in Ewing's sarcoma. Int J Cancer 119:1039-1046.
3. Bourhis XL, Toillon RA, Boilly B, Hondermarck H. 2000. Autocrine and paracrine growth inhibitors of breast cancer cells. Breast Cancer Res Treat 60:251-258.
4. Boyle B, Zhao X, Cohen P, Feldman D. 2001. Insulin-like growth factor binding protein-3 mediates 1 alpha,25-dihydroxyvitamin d(3) growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1. J Urol 165:1319-1324.
5. Burkhart DL, Sage J. 2008. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 8: 671-682.
6. Burrows C, Holly JM, Laurence NJ, Vernon EG, Carter JV, Clark MA, McIntosh J, McCaig C, Winters ZE, Perks CM. 2006. Insulin-like growth factor binding protein 3 has opposing actions on malignant and nonmalignant breast epithelial cells that are each reversible and dependent upon cholesterol-stabilized integrin receptor complexes. Endocrinology 147:3484-3500.
7. Butt AJ, Firth SM, King MA, Baxter RC. 2000. Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells. J Biol Chem 275:39174-39181.
8. Butt AJ, Martin JL, Dickson KA, McDougall F, Firth SM, Baxter RC. 2004. Insulin-like growth factor binding protein-3 expression is associated with growth stimulation of T47D human breast cancer cells: The role of altered epidermal growth factor signaling. J Clin Endocrinol Metab 89:1950-1956.
9. Chang KH, Chan-Ling T, McFarland EL, Afzal A, Pan H, Baxter LC, Shaw LC, Caballero S, Sengupta N, Li Calzi S, et al. 2007. IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development. Proc Natl Acad Sci USA 104:10595-10600.
10. Clemmons DR, Camacho-Hubner C, Coronado E, Osborne CK. 1990. Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: Correlation with estrogen receptor status. Endocrinology 127:2679-2686.
11. Connell-Crowley L, Harper JW, Goodrich DW. 1997. Cyclin D1/ Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol Biol Cell 8:287-301.
12. De Leon DD, Bakker B, Wilson DM, Hintz RL, Rosenfeld RG. 1988. Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines. Biochem Biophys Res Commun 152:398-405.
13. De Leon DD,Wilson DM, Powers M, Rosenfeld RG. 1992. Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells. Growth Factors 6:327-336.
14. De Mellow JS, Baxter RC. 1988. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun 156:199-204.
15. Dunn SE, Torres JV, Nihei N, Barrett JC. 2000. The insulin-like growth factor-1 elevates urokinase-type plasminogen activator-1 in human breast cancer cells: A new avenue for breast cancer therapy. Mol Carcinog 27:10-17.
16. Fanayan S, Firth SM, Butt AJ, Baxter RC. 2000. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGFbeta) and the type II TGF-beta receptor. J Biol Chem 275: 39146-39151.
17. Figueroa JA, Jackson JG, McGuire WL, Krywicki RF, Yee D. 1993. Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status. J Cell Biochem 52:196-205. (Pubitemid 23179294)
18. Firth SM, Baxter RC. 2002. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854.
19. Firth SM, Fanayan S, Benn D, Baxter RC. 1998. Development of resistance to insulin-like growth factor binding protein-3 in transfected T47D breast cancer cells. Biochem Biophys Res Commun 246:325-329.
20. Firth SM, Ganeshprasad U, Poronnik P, Cook DL, Baxter RC. 1999. Adenoviral-mediated expression of human insulin-like growth factor-binding protein-3. Protein Exp Purif 16:202-211.
21. FrommerKW, Reichenmiller K, Schutt BS, Hoeflich A, Ranke MB, Dodt G, Elmlinger MW. 2006. IGF-independent effects of IGFBP-2 on the human breast cancer cell line Hs578T. J Mol Endocrinol 37:13-23.
22. Granata R, Trovato L, Garbarino G, Taliano M, Ponti R, Sala G, Ghidoni R, Ghigo E. 2004. Dual effects of IGFBP-3 on endothelial cell apoptosis and survival: Involvement of the sphingolipid signaling pathways. FASEB J 18:1456-1458.
23. Granata R, Trovato L, Lupia E, Sala G, Settanni F, Camussi G, Ghidoni R, Ghigo E. 2007. Insulin-like growth factor binding protein-3 induces angiogenesis through IGF-I- and SphK1- dependent mechanisms. J Thromb Haemost 5:835-845.
24. Gucev ZS, Oh Y, Kelley KM, Rosenfeld RG. 1996. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells. Cancer Res 56:1545-1550.
25. Gui Y, Murphy LJ. 2001. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) binds to fibronectin (FN): Demonstration of IGF-I/IGFBP-3/fn ternary complexes in human plasma. J Clin Endocrinol Metab 86:2104-2110.
26. Harper JW. 2001. Protein destruction: Adapting roles for Cks proteins. Curr Biol 11:R431-R435.
27. Herrera-Gayol A, Jothy S. 2002. Effect of hyaluronan on xenotransplanted breast cancer. Exp Mol Pathol 72:179-185.
28. Huynh H, Yang X, Pollak M. 1996. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. J Biol Chem 271:1016-1021.
29. Jones JI, Clemmons DR. 1995. Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 16:3-34.
30. Katz M, Amit I, Yarden Y. 2007. Regulation of MAPKs by growth factors and receptor tyrosine kinases. Biochim Biophys Acta 1773:1161-1176.
31. Lee K-W, Liu B, Ma L, Li H, Bang P, Koeffler HP, Cohen P. 2004. Cellular internalization of insulin-like growth factor binding protein-3: Distinct endocytic pathways facilitate re-uptake and nuclear localization. J Biol Chem 279:469-476.
32. Lee EY, Jeon MJ, YangW, Shin I. 2009. Effect of p27 on motility of MDA-MB-231 breast cancer cells. Oncol Rep 21:1621-1625.
33. LeRoith D, Roberts CT, Jr. 2003. The insulin-like growth factor system and cancer. Cancer Lett 195:127-137.
34. Lester RD, JoM, Campana WM, Gonias SL. 2005. Erythropoietin promotes MCF-7 breast cancer cell migration by an ERK/ mitogen-activated protein kinase-dependent pathway and is primarily responsible for the increase in migration observed in hypoxia. J Biol Chem 280:39273-39277.
35. Liu B,Weinzimer SA, Gibson TB, Mascarenhas D, Cohen P. 2003. Type Ia collagen is an IGFBP-3 binding protein. Growth Horm IGF Res 13:89-97.
36. Martin JL, Baxter RC. 1999. Oncogenic ras causes resistance to the growth inhibitor insulin-like growth factor binding protein-3 (IGFBP-3) in breast cancer cells. J Biol Chem 274: 16407-16411.
37. Martin JL, Coverley JA, Pattison ST, Baxter RC. 1995. Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: Stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol. Endocrinology 136:1219-1226.
38. Massoner P, ColleselliD, Matscheski A, Pircher H, Geley S, Jansen- Duerr P, Klocker H. 2009. Novel mechanism of insulin-like growth factor binding protein 3 (IGFBP-3) on prostate cancer cells: Inhibition of proliferation, adhesion and motility. Endocr Relat Cancer. June 9 [Epub ahead of print].
39. McCaig C, Perks CM, Holly JM. 2002. Intrinsic actions of IGFBP- 3 and IGFBP-5 on Hs578T breast cancer epithelial cells: Inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin. J Cell Sci 115: 4293-4303.
40. Mishra S, Raz A, Murphy LJ. 2004. Insulin-like growth factor binding protein-3 interacts with autocrine motility factor/ phosphoglucose isomerase (AMF/PGI) and inhibits the AMF/ PGI function. Cancer Res 64:2516-2522.
41. Mu L, Katsaros D, Wiley A, Lu L, De La Longrais IA, Smith S, Khubchandani S, Sochirca O, Arisio R, Yu H. 2009. Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics. Breast Cancer Res Treat 115:151-162.
42. Oh Y, Muller HL, Lamson G, Rosenfeld RG. 1993. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J Biol Chem 268:14964-14971.
43. Oh Y, Gucev Z, Ng L, Muller HL, Rosenfeld RG. 1995. Antiproliferative actions of insulin-like growth factor binding protein (IGFBP)-3 in human breast cancer cells. Prog Growth Factor Res 6:503-512.
44. Oh SH, Lee OH, Schroeder CP, Oh YW, Ke S, Cha HJ, Park RW, Onn A, Herbst RS, Li C, et al. 2006. Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor-independent urokinasetype plasminogen activator inhibition. Mol Cancer Ther 5: 2685-2695.
45. O'Rear L, Longobardi L, Torello M, Law BK, Moses HL, Chiarelli F, Spagnoli A. 2005. Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-(beta) in mesenchymal chondroprogenitor cell growth. J Mol Endocrinol 34: 723-737.
46. Peng L, Wang J, Malloy PJ, Feldman D. 2008. The role of insulinlike growth factor binding protein-3 in the growth inhibitory actions of androgens in LNCaP human prostate cancer cells. Int J Cancer 122:558-566.
47. Perks CM, Bowen S, Gill ZP, Newcomb PV, Holly JM. 1999. Differential IGF-independent effects of insulin-like growth factor binding proteins (1-6) on apoptosis of breast epithelial cells. J Cell Biochem 75:652-664.
48. Perks CM, McCaig C, Holly JM. 2000. Differential insulin-like growth factor (IGF)-independent interactions of IGF binding protein-3 and IGF binding protein-5 on apoptosis in human breast cancer cells. Involvement of the mitochondria. J Cell Biochem 80:248-258.
49. Peyrat JP, Bonneterre J, Dusanter-Fourt I, Leroy-Martin B, Djiane J, Demaille A. 1989. Characterization of insulin-like growth factor 1 receptors (IGF1-R) in human breast cancer cell lines. Bull Cancer 76:311-319.
50. Rajah R, Valentinis B, Cohen P. 1997. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 272:12181-12188.
51. Ren Z, Shin A, Cai Q, Shu XO, Gao YT, Zheng W. 2007. IGFBP3 mRNA expression in benign and malignant breast tumors. Breast Cancer Res 9:R2.
52. Rocha RL, Hilsenbeck SG, Jackson JG, Lee AV, Figueroa JA, Yee D. 1996. Correlation of insulin-like growth factor-binding protein-3 messenger RNAwith protein expression in primary breast cancer tissues: Detection of higher levels in tumors with poor prognostic features. J Natl Cancer Inst 88:601-606.
53. Samani AA, Yakar S, LeRoithD, Brodt P. 2007. The role of the IGF system in cancer growth and metastasis: Overview and recent insights. Endocr Rev 28:20-47.
54. Seville LL, Shah N, Westwell AD, Chan WC. 2005. Modulation of pRB/E2F functions in the regulation of cell cycle and in cancer. Curr Cancer Drug Targets 5:159-170.
55. Shao ZM, Sheikh MS, Ordonez JV, Feng P, Kute T, Chen JC, Aisner S, Schnaper L, LeRoith D, Roberts CT, Jr, et al. 1992. IGFBP-3 gene expression and estrogen receptor status in human breast carcinoma. Cancer Res 52:5100-5103.
56. Sheen-Chen SM, Zhang H, Huang CC, Tang RP. 2009. Insulin-like growth factor-binding protein-3 in breast cancer: Analysis with tissue microarray. Anticancer Res 29:1131-1135.
57. Sheikh MS, Shao ZM, Clemmons DR, LeRoith D, Roberts CT, Jr, Fontana JA. 1992. Identification of the insulin-like growth factor binding proteins 5 and 6 (IGFBP-5 and 6) in human breast cancer cells. Biochem Biophys Res Commun 183:1003-1010.
58. Torng PL, Lee YC, Huang CY, Ye JH, Lin YS, ChuYW, Huang SC, Cohen P, Wu CW, Lin CT. 2008. Insulin-like growth factor binding protein-3 (IGFBP-3) acts as an invasion-metastasis suppressor in ovarian endometrioid carcinoma. Oncogene 27: 2137-2147.
59. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P. 1995. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 9:361-367.
60. Xi Y, Nakajima G, Hamil T, Fodstad O, Riker A, Ju J. 2006. Association of insulin-like growth factor binding protein-3 expression with melanoma progression. Mol Cancer Ther 5: 3078-3084.
61. You J, Mi D, Zhou X, Qiao L, Zhang H, Zhang X, Ye L. 2009. A positive feedback between activated extracellularly regulated kinase and cyclooxygenase/lipoxygenase maintains proliferation and migration of breast cancer cells. Endocrinology 150: 1607-1617.
62. Yu H, Levesque MA, Khosravi MJ, Papanastasiou-Diamandi A, Clark GM, Diamandis EP. 1998. Insulin-like growth factorbinding protein-3 and breast cancer survival. Int J Cancer 79: 624-628.